SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-19-004601
Filing Date
2019-03-21
Accepted
2019-03-21 12:17:32
Documents
1
Period of Report
2018-12-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6034
  Complete submission text file 0001213900-19-004601.txt   8457
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Issuer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 7 F., NO. 3-2, PARK ST., NANGANG DIST. TAIPEI F5 11503
Business Address 7 F., NO. 3-2, PARK ST., NANGANG DIST. TAIPEI F5 11503 886 2 2655 8551
Bioengine Capital Inc. (Reporting) CIK: 0001770197 (see all company filings)

State of Incorp.: F5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-26422 | Film No.: 19696387

Mailing Address 7 ., NO. 3-2, PARK ST. NANGANG DIST. TAIPEI F5 11503
Business Address 7 ., NO. 3-2, PARK ST. NANGANG DIST. TAIPEI F5 11503 886 2 2655 8680
Center Laboratories, Inc. (Reporting) CIK: 0001770423 (see all company filings)

State of Incorp.: F5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-26422 | Film No.: 19696388